This document is an excerpt from the EUR-Lex website
Document C:2014:436:TOC
Official Journal of the European Union, C 436, 5 December 2014
Official Journal of the European Union, C 436, 5 December 2014
Official Journal of the European Union, C 436, 5 December 2014
ISSN 1977-091X |
||
Official Journal of the European Union |
C 436 |
|
![]() |
||
English edition |
Information and Notices |
Volume 57 |
Notice No |
Contents |
page |
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2014/C 436/01 |
Non-opposition to a notified concentration (Case M.7011 — SNCF / SNCB / Thalys JV) ( 1 ) |
1 |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
Council |
|
2014/C 436/02 |
2 |
|
|
European Commission |
|
2014/C 436/03 |
6 |
|
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2014/C 436/04 |
Prior notification of a concentration (Case M.7463 — CVC/Betafence) — Candidate case for simplified procedure ( 1 ) |
7 |
2014/C 436/05 |
Prior notification of a concentration (Case M.7439 — EPH/Eggborough HoldCo 2) — Candidate case for simplified procedure ( 1 ) |
8 |
2014/C 436/06 |
Prior notification of a concentration (Case M.7468 — Oji Holdings/Itochu Corporation/Sales and Production JVs) — Candidate case for simplified procedure ( 1 ) |
9 |
2014/C 436/07 |
Prior notification of a concentration (Case M.7276 — GlaxoSmithKline/Novartis vaccines business (excl. influenza)/Novartis consumer health business) ( 1 ) |
10 |
2014/C 436/08 |
Prior notification of a concentration (Case M.7275 — Novartis/GlaxoSmithKline oncology business) ( 1 ) |
11 |
|
Corrigenda |
|
2014/C 436/09 |
12 |
|
|
|
|
(1) Text with EEA relevance |
EN |
|